Trial
NCT05441488
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
Phase IIISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AB Science
Collaborators
—
Condition
Progressive Multiple Sclerosis
Intervention
Placebo
Why stopped
The study has been suspended but may start again in the future.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-06